Race Against Blood Cancer Annual Report for Year Ended 31 March 2025
The Trustees of Race Against Blood Cancer are pleased to present our Annual Report which covers the fiscal year 1st April 2024 to 31st March 2025.
In the UK blood cancer patients from a Global Majority background have a significantly higher post-diagnosis mortality rate when compared to White Northern European patients. A White Northern European patient has a 70% or more chance of finding a match compared to a 20% or less chance for a Global Majority patient.
Race against Blood Cancer was founded in 2015 by a group of friends who received the devastating news of a close friend s blood cancer diagnosis. A lifesaving match depends on finding a stem cell or bone marrow donor with a similar ethnicity as the patient and it was even more devastating to realise that the chance of finding a match was significantly lower because of a mixed ethnic background. This group of friends were inspired to join the fight for health equality and give every blood cancer patient the best possible chance of surviving blood cancer regardless of background.
At RABC our vision is that one day, all blood cancer patients will have the equal opportunity of a quality stem cell match.
Our mission is to save more lives by addressing the stark inequality of finding a stem cell match for Global Majority blood cancer patients by recruiting more people from these backgrounds onto the UK s register of stem cell and bone marrow donors.
To achieve our mission we deliver one of the only UK programmes aiming to engage the public in a face-to-face capacity and recruit new people from Global Majority backgrounds onto the donor register. We focus our efforts on partnering with organisations and in areas which have high levels of our target population, building trust and relationships with organisations and communities to recruit as many Global Majority donors as possible each year.
Our 'Save a Life Programme (SLP) has developed over 9-years and consists of Donor Drive events, where we directly sign people up to the stem cell and bone marrow donor register. We ve recently added separate Education Talks, which raise awareness of the issue, where each talk is followed by a Donor Drive event. This approach slows our recruitment in real terms but invests in longer-term attitude change in people we hope will become lifelong advocates. Our programme is delivered across the Midlands with intermittent activity in London, and we have a national reach because the donor registry is accessed across the UK.
For countless people living with blood cancer and other blood disorders, the search for a matching stem cell donor is a race against time. Your willingness to donate could offer them the priceless gift of a second chance at life.
Page 1 Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ
Chair of Trustees Statement for period April 2024 to March 2025
Introduction
As we approach our 10-year anniversary, its critical that we align on the strategic delivery plan and expectations to safeguard the future of the charity. Since inception, we have signed up over 11,000 donors and more than 20 potential lifesaving donor matches, making us one of the biggest UK partners to DKMS and, more recently, Anthony Nolan.
Despite our achievements, we ve found it challenging to achieve financial stability and face to face recruitment events post-COVID, though a new strategic plan is currently being prepared to address both these issues going forward. Our recruitment of a specialist fundraising trustee in the previous period has paid dividends and we are moving in a positive direction year-on-year with our fundraising.
Achievements and Challenges
During the period from April 2024 to March 2025, we hosted 69 events (donor drives and YEP presentations), signing up over 787 potential lifesavers. We kicked off a multi-year partnership with The Anthony Nolan charity aimed at funding our Youth Education Programme (YEP). We contributed creation of the first Global Majority recruitment targets and we also began rebuilding our website, funded by The National Lottery.
However, we faced challenges such as difficulty in generating funds, struggles in recruiting volunteers and a decrease in the average number of sign-ups per donor drive as we shifted to more closed environments like schools and colleges as part of the YEP. These challenges only strengthen our resolve to set and achieve more ambitious Global Majority recruitment targets, delivering high quality donors who go on to donate when matched.
Impact Stories
The APPG report launch allowed us to build closer relationships with key stakeholders across the Department for Health, NHS Blood & Transplant, and other smaller charities. Our collaboration with Anthony Nolan significantly improved donor recruitment from two of our target groups from males and those aged under 30 both of whom offer better outcomes for blood cancer patients with less risk of complications.
Partner Feedback
Holly Gooch, Partnerships Manager at Anthony Nolan, shared her positive feedback:
been working in Partnership since 2019 and really stepped up in activity from 2021 when RABC ran a series of very successful donor recruitment events with the National Citizen Service. At the end of 2023, we updated our recruitment agreement and RABC proposed an ambitious recruitment strategy and KPIs, which I am delighted to say they have surpassed.
Page 2 Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ
Race Against Blood Cancer set out to recruit 300 people to the register across the first 3 months of this year, a target which is approximately 3 times the number of people they recruited in the entirety of last year. In this partnership, we want to recruit quality donors who we know will provide the best possible outcomes for patients. Part of this is recruiting young donors, between the ages of 16-23. 84% of R -23 (compared to Anthony Nolan overall which is 80%). The other key area of focus is recruiting more donors from minority ethnic backgrounds as we are committed, at RABC and AN, to ensuring that every patient has access to a stem cell transplant. 38% of the people RABC recruited are from minority ethnic backgrounds, compared to 23% on average across Anthony Nolan. Not only are RABC committed to recruiting donors, but they have also cruiting quality donors who will go on to save the lives of patients now and in the future.
It has been so impressive to see RABC pivot their approach to recruitment this year to engage more young people - forging new connections, trialling new approaches and successfully shifting their focus to a younger, more targeted audience. For the year ahead, RABC are looking to develop an education programme to deliver to local schools and colleges so they can reach even more young people where ts, bust myths and help each individual to make a safe, informed decision about donation.
see the lifesaving impact they have in the local community and beyo
Financial Overview
Delivering our essential programme of work is dependent on our fundraising efforts which are led by our fundraising trustee, supported by the General Manager. For the year ended 31/03/2025, there was a surplus of 32,228 compared to income deficit of 16,515 in prior year (ending 31/03/2024). In 2024/25 our income was 92,733 (2023/24: 43,242) versus our expenditure of 60,505 (2023/24: 59,757). This represented an improvement as we began to feel the benefit of bringing on our fundraising specialist trustee. However, to move towards our ambitions, we require a more diverse mix of income streams and better distribution across these streams.
Income comes primarily from Trusts and Grants (90%) with individual donations and individual supporters fundraising effort making up the remainder (10%).
We are in the final stretch of website redevelopment and looking forward to a new site that enables our ambitions to build stronger ongoing relationships with our supporters, host patient appeals, and actively engage with our audience.
Strategic Goals and Objectives
Our ambitions for the next three fiscal years (FY 25-26, 26-27, and 27-28) include expanding our geographical coverage, establishing financial sustainability, further professionalising our structure and operations, educating people with a focus on youth-centred programmes, and collaborating through partnerships.
Page 3 Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ
Key Actions for 2025-2026
Deepen and consolidate Youth Education Programme activity.
Increase donor recruitment figures in the over 30s through a new corporate activity programme Introduction of a new three-year organisational strategy for 2025-2028 Skills audit and recruitment of new trustees.
A renewed focus on development of fundraising income streams.
Re-establish activities in London.
Governance and Leadership
Race Against Blood Cancer is a Charitable Incorporated Organisation (CIO), registered with the Charity Commission for England and Wales under number 1162696. The charity was formally established by constitution on 16 July 2015. Our team consists of a General Manager (0.5 FTE), 1 FTE Community Engagement Manager (CEM), 7 trustees, and a pool of 20 volunteers supporting our CEM.
Stakeholder Feedback
We received positive feedback from donors who appreciated our transparency and impact stories. Volunteers expressed a sense of fulfilment and pride in being part of our mission. Beneficiaries, particularly patients and their families, were grateful for the hope and support provided by our efforts.
Acknowledgements
The Trustees would like to thank the following individuals, companies and charitable trusts and organisations for their support throughout 2024/25:
10,000 Donors Coventry College Sandwell College African Caribbean Leukaemia Trust (ACLT) Coventry University Shrewsbury College Group South & City College Anthony Nolan Defined Ridez Birmingham DKMS UK Dudley College of Technology Telford United FC National Black, Asian, Mixed and Minority Ethnic Transplant Heart of Worcestershire Association (NBTA) College The Hex Group Newcastle and Stafford Sue Harris Trust Colleges Group Wakes Team Margot Park Run Walton Wobble 5k Anytime Fitness Really Neet The National Lottery
Signed on behalf of the board on 23 October 2025
Jacob Knox-Hooke
Chair of Trustees
Page 4 Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ
Race Against Blood Cancer
Charity No. 1162696
Company No. CE005053
Trustees' Report and Unaudited Accounts
31 March 2025
Race Against Blood Cancer Contents
| Pages | |
|---|---|
| Trustees' Annual Report | 6 |
| Independent Examiner's Report | 7 |
| Statement of Financial Activities | 8 |
| Summary Income and Expenditure Account | 9 |
| Balance Sheet | 10 |
| Statement of Cash flows | 11 |
| Notes to the Accounts | 12 to 17 |
| Detailed Statement of Financial Activities | 18 to 19 |
Page 5
Race Against Blood Cancer
Trustees Annual Report
The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the unaudited financial statements of the charity for the year ended 31 March 2025.
REFERENCE AND ADMINISTRATIVE DETAILS
Company No. CE005053
Charity No. 1162696
Registered Office
71-75 Shelton Street Covent Garden London WC2H 9JQ
Directors and Trustees
The Directors of the charitable company are its Trustees for the purposes of charity law. The following Directors and Trustees served during the year:
J. Bates G. Fiske (Resigned 1 October 2024) D. Gardner M.M. Gardner J.I.B. Knox-Hooke H. Shah R.O. Sisupalan (Appointed on 08 October 2024) B. Westwood
Accountants
Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield HD1 5JL
The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006 and in accordance with the Charities SORP (FRS 102).
Signed on behalf of the board
J.I.B. Knox-Hooke Trustee 23 October 2025
Page 6
Race Against Blood Cancer
Independent Examiners Report
Independent Examiner's Report to the trustees of Race Against Blood Cancer
I report to the charity trustees on my examination of the financial statements of Race Against Blood Cancer for the year ended 31 March 2025.
Responsibilities and basis of report
As the charity's trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act.
Having satisfied myself that the financial statements of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's financial statements as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
Independent examiner's statement
I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe:
-
Act other than any requirement that the financial statements give a 'true and fair' view which is not a matter considered as part of an independent examination; or
-
the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Vicky Newham CPAA
Solutions Accountancy & Bookkeeping Ltd 1 The Mews
Little Brunswick Street
Huddersfield
HD1 5JL
23 October 2025
Page 7
Race Against Blood Cancer
Statement of Financial Activities
for the year ended 31 March 2025
| Notes Income and endowments from: Donations and legacies 4 Other 5 Total Expenditure on: Raising funds 6 Other 7 Total Net gains on investments Net income/(expenditure) 8 Transfers between funds Net income/(expenditure) before other gains/(losses) Other gains and losses Net movement in funds Reconciliation of funds: Total funds brought forward Total funds carried forward |
Unrestricted funds 2025 82,810 127 |
Restricted funds 2025 1,000 8,796 |
Total funds 2025 83,810 8,923 |
Total funds 2024 34,385 8,857 |
|---|---|---|---|---|
| 82,937 1,608 50,424 |
9,796 - 8,473 |
92,733 1,608 58,897 |
43,242 694 59,063 |
|
| 52,032 - |
8,473 - |
60,505 - |
59,757 - |
|
| 30,905 - |
1,323 - |
32,228 - |
(16,515) - |
|
| 30,905 | 1,323 | 32,228 | (16,515) | |
| 30,905 (1,770) |
1,323 6,997 |
32,228 5,227 |
(16,515) 21,742 |
|
| 29,135 | 8,320 | 37,455 | 5,227 |
Page 8
Race Against Blood Cancer
Summary Income and Expenditure Account
for the year ended 31 March 2025
| Income Gross income for the year Expenditure Interest payable Total expenditure for the year Net income/(expenditure) before tax for the year Net income /(expenditure )for the year |
2025 92,733 92,733 60,505 - 60,505 32,228 32,228 |
2024 43,242 |
|---|---|---|
| 43,242 | ||
| 59,536 221 |
||
| 59,757 | ||
| (16,515) | ||
| (16,515) |
Page 9
Race Against Blood Cancer
Balance Sheet
at 31 March 2025
| Company No. CE005053 Notes 2025 Current assets Cash at bank and in hand 42,826 42,826 Creditors:Amount falling due within one year 10 (4,662) Net current assets 38,164 Total assets less current liabilities 38,164 Creditors:Amounts falling due after more than one year 11 (709) Net assets excluding pension asset or liability 37,455 Total net assets 37,455 The funds of the charity Restricted funds 12 Restricted income funds 8,320 8,320 Unrestricted funds 12 General funds 29,135 29,135 Reserves 12 Total funds 37,455 |
2024 13,758 |
|---|---|
| 13,758 (4,502) |
|
| 9,256 9,256 (4,029) |
|
| 5,227 | |
| 5,227 | |
| 6,997 | |
| 6,997 (1,770) |
|
| (1,770) | |
| 5,227 |
These accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.
For the year ended 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
Approved by the board on 23 October 2025
And signed on its behalf by:
J.I.B. Knox-Hooke Trustee
23 October 2025
Page 10
Race Against Blood Cancer
Statement of Cash flows
for the year ended 31 March 2025
| Cash flows from operating activities Net income/(expenditure) per Statement of Financial Activities Adjustments for: Dividends, interest and rents from investments Increase in trade and other payables Net cash provided by/(used in) operating activities Cash flows from investing activities Dividends, interest and rents from investments Net cash from investing activities Cash flows from financing activities Repayment of borrowings Net cash used in financing activities Net increase/(decrease) in cash and cash equivalents Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year Components of cash and cash equivalents Cash and bank balances |
2025 32,228 (8,923) 160 23,465 8,923 8,923 (3,320) (3,320) 29,068 13,758 42,826 42,826 42,826 |
2024 (16,515) (8,857) 522 |
|---|---|---|
| (24,850) 8,857 |
||
| 8,857 | ||
| (2,974) | ||
| (2,974) | ||
| (18,967) | ||
| 32,725 | ||
| 13,758 | ||
| 13,758 | ||
| 13,758 |
Page 11
Race Against Blood Cancer
Notes to the Accounts
for the year ended 31 March 2025
- 1 Accounting policies
Basis of preparation
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
Change in basis of accounting or to previous accounts
There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.
Fund accounting
Unrestricted funds These are available for use at the discretion of the trustees in furtherance of the general objects of the charity. Designated funds These are unrestricted funds earmarked by the trustees for particular purposes. Revaluation funds These are unrestricted funds which include a revaluation reserve representing the restatement of investment assets at their market values. Restricted funds These are available for use subject to restrictions imposed by the donor or through terms of an appeal.
Income
Recognition of Income is included in the Statement of Financial Activities (SoFA) when the charity income becomes entitled to, and virtually certain to receive, the income and the amount of the income can be measured with sufficient reliability. Donations and Voluntary income received by way of grants, donations and gifts is included in the legacies the SoFA when receivable and only when the Charity has unconditional entitlement to the income. Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable.
Page 12
Race Against Blood Cancer Notes to the Accounts
Expenditure
-
Recognition of Expenditure is recognised on an accruals basis. Expenditure includes any VAT which expenditure cannot be fully recovered, and is reported as part of the expenditure to which it relates.
-
Expenditure on These comprise the costs associated with attracting voluntary income, fundraising raising funds trading costs and investment management costs. Expenditure on These comprise the costs incurred by the Charity in the delivery of its activities and charitable activities services in the furtherance of its objects, including the making of grants and governance costs.
-
Grants payable All grant expenditure is accounted for on an actual paid basis plus an accrual for grants that have been approved by the trustees at the end of the year but not yet paid.
-
Governance costs These include those costs associated with meeting the constitutional and statutory requirements of the Charity, including any audit/independent examination fees, costs linked to the strategic management of the Charity, together with a share of other administration costs.
-
Other expenditure These are support costs not allocated to a particular activity.
Taxation
The charity is exempt from corporation tax on its charitable activities.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand.
Trade and other creditors
Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
Pension costs
The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
2 Company status
The company is a private company limited by guarantee and consequently does not have share capital.
Page 13
Race Against Blood Cancer
Notes to the Accounts
3 Statement of Financial Activities - prior year
| 3 Statement of Financial Activities - prior year |
||||
|---|---|---|---|---|
| Income and endowments from: Donations and legacies Other Total Expenditure on: Raising funds Other Total Net income Net income before other gains/(losses) Other gains and losses: Net movement in funds Reconciliation of funds: Total funds brought forward Total funds carried forward 4 Income from donations and legacies Donations From Events General Donations Regular Donations 5 Other income Other Grant Income |
Unrestricted 11,441 70,109 1,260 82,810 Unrestricted 127 127 |
Unrestricted funds 2024 14,385 300 14,685 694 24,203 24,897 (10,212) (10,212) (10,212) 8,442 (1,770) Restricted - 1,000 - 1,000 Restricted 8,796 8,796 |
Restricted funds 2024 20,000 8,557 28,557 - 34,860 34,860 (6,303) (6,303) (6,303) 13,300 6,997 Total 2025 11,441 71,109 1,260 83,810 Total 2025 8,923 8,923 |
Total funds 2024 34,385 8,857 |
| 43,242 694 59,063 |
||||
| 59,757 | ||||
| (16,515) | ||||
| (16,515) | ||||
| (16,515) 21,742 |
||||
| 5,227 | ||||
| Total 2024 10,494 23,831 60 |
||||
| 34,385 | ||||
| Total 2024 8,857 |
||||
| 8,857 |
Page 14
Race Against Blood Cancer
Notes to the Accounts
| 6 Expenditure on raising funds Costs of generating voluntary income Adhoc Donations MyDonate Donations From Events 7 Other expenditure Bank loan and overdraft interest payable Employee costs Premises costs General administrative costs Legal and professional costs 8 Net income/(expenditure) before transfers This is stated after charging: Independent Examiner's fee 9 Staff costs Salaries and wages Pension costs No employee received emoluments in excess 10 Creditors: amounts falling due within one year Bank loans and overdrafts Other taxes and social security Other creditors Accruals |
Unrestricted - 46,804 450 1,500 1,670 50,424 of |
Unrestricted 397 1,211 1,608 Restricted - 5,353 - 3,120 - 8,473 2025 650 2025 51,059 1,098 52,157 2025 3,195 387 430 650 4,662 |
Total 2025 397 1,211 1,608 Total 2025 - 52,157 450 4,620 1,670 58,897 |
Total 2024 62 632 |
|---|---|---|---|---|
| 694 | ||||
| Total 2024 221 50,544 - 3,014 5,284 |
||||
| 59,063 | ||||
| 2024 650 2024 49,530 1,014 |
||||
| 50,544 | ||||
| 2024 3,195 445 212 650 |
||||
| 4,502 |
Page 15
Race Against Blood Cancer
Notes to the Accounts
11 Creditors:
amounts falling due after more than one year
----- Start of picture text -----
2025 2024
Bank loans and overdrafts 709 4,029
709 4,029
12 Movement in funds
Incoming
resources
At 31
(including Resources
March
other expended
2025
At 1 April gains/losses
2024 )
Restricted funds:
Restricted income funds:
- -
Shropshire Community Fund 1,000 1,000
The National Lottery 6,997 8,796 (8,473) 7,320
Total 6,997 9,796 (8,473) 8,320
Unrestricted funds:
General funds (1,770) 82,937 (52,032) 29,135
Total funds 5,227 92,733 (60,505) 37,455
Purposes and restrictions in relation to the funds:
Restricted funds:
Shropshire Community Fund Youth Engagement Programme
The National Lottery GM Salary and Website development
----- End of picture text -----
13 Analysis of net assets between funds
| Analysis of net assets between funds | ||
|---|---|---|
| Net current assets Creditors due in more than one year and provisions |
Unrestricted funds 38,164 (709) 37,455 |
Total 38,164 (709) |
| 37,455 |
Page 16
Race Against Blood Cancer
Notes to the Accounts
14 Reconciliation of net debt
| 14 Reconciliation of net debt | |||
|---|---|---|---|
| Cash and cash equivalents Bank loans Net debt |
At 1 April 2024 |
Cash flows | At 31 March 2025 |
| 13,758 | 29,068 | 42,826 | |
| 13,758 (7,224) (7,224) 6,534 |
29,068 3,320 3,320 32,388 |
42,826 (3,904) |
|
| (3,904) | |||
| 38,922 | |||
| 15 Commitments Pension commitments The pension cost charge to the company amounted to: 16 Related party disclosures Controlling party |
2025 1,098 |
2024 1,014 |
|
The company is limited by guarantee and has no share capital; thus no single party controls the company.
Page 17
Race Against Blood Cancer
Detailed Statement of Financial Activities
for the year ended 31 March 2025
| Income and endowments from: Donations and legacies Donations From Events General Donations Regular Donations Other Other Grant Income Total income and endowments Expenditure on: Costs of generating donations and legacies Adhoc Donations MyDonate Donations From Events Total of expenditure on raising funds Other expenditure Bank loan and overdraft interest payable Employee costs Salaries/wages Pension costs Premises costs Rent General administrative costs, including depreciation and amortisation General insurances Software, IT support and related costs Stationery and printing Telephone, fax and broadband Legal and professional costs |
Unrestricted funds 2025 11,441 70,109 1,260 |
Restricted funds 2025 - 1,000 - |
Total funds 2025 11,441 71,109 1,260 |
Total funds 2024 10,494 23,831 60 |
|---|---|---|---|---|
| 82,810 | 1,000 | 83,810 | 34,385 | |
| 127 | 8,796 | 8,923 | 8,857 | |
| 127 | 8,796 | 8,923 | 8,857 | |
| 82,937 397 1,211 |
9,796 - - |
92,733 397 1,211 |
43,242 62 632 |
|
| 1,608 | - | 1,608 | 694 | |
| 1,608 - |
- - |
1,608 - |
694 221 |
|
| - | - | - | 221 | |
| 45,706 1,098 |
5,353 - |
51,059 1,098 |
49,530 1,014 |
|
| 46,804 | 5,353 | 52,157 | 50,544 | |
| 450 | - | 450 | - | |
| 450 | - | 450 | - | |
| 219 457 141 683 |
- 3,120 - - |
219 3,577 141 683 |
233 1,980 162 639 |
|
| 1,500 | 3,120 | 4,620 | 3,014 | |
Page 18
Race Against Blood Cancer Detailed Statement of Financial Activities
| Race Against Blood Cancer Detailed Statement of Financial Activities |
||||
|---|---|---|---|---|
| Accountancy and bookkeeping Consultancy fees Total of expenditure of other costs Total expenditure Net gains on investments Net income/(expenditure) Net income/(expenditure) before other gains/(losses) Other Gains Net movement in funds Reconciliation of funds: Total funds brought forward Total funds carried forward |
1,670 - |
- - |
1,670 - |
934 4,350 |
| 1,670 | - | 1,670 | 5,284 | |
| 50,424 | 8,473 | 58,897 | 59,063 | |
| 52,032 - |
8,473 - |
60,505 - |
59,757 - |
|
| 30,905 | 1,323 | 32,228 | (16,515) | |
| 30,905 - |
1,323 | 32,228 - |
(16,515) - |
|
| - | ||||
| 30,905 | 1,323 | 32,228 | (16,515) | |
| (1,770) | 6,997 | 5,227 | 21,742 | |
| 29,135 | 8,320 | 37,455 | 5,227 |
Page 19